Synopsis of arachidonic acid metabolism: A review

Rich, 1993, Conformational analysis of arachidonic and related fatty acids using molecular dynamics simulations, Biochim Biophys Acta, 1178, 87, 10.1016/0167-4889(93)90113-4 Brash, 2001, Arachidonic acid as a bioactive molecule, J Clin Invest, 107, 1339, 10.1172/JCI13210 Taber, 1998, Assessment of the arachidonic acid content in foods commonly consumed in the American diet, Lipids, 33, 1151, 10.1007/s11745-998-0317-4 Sinclair, 1994, Diets rich in lean beef increase arachidonic acid and long-chain ω3 polyunsaturated fatty acid levels in plasma phospholipids, Lipids, 29, 337, 10.1007/BF02537187 Li, 1998, Contribution of meat fat to dietary arachidonic acid, Lipids, 33, 437, 10.1007/s11745-998-0225-7 Lee, 2016, Fatty acid desaturases, polyunsaturated fatty acid regulation, and biotechnological advances, Nutrients, 8, 1, 10.3390/nu8010023 Zock, 2016, Progressing insights into the role of dietary fats in the prevention of cardiovascular disease, Current Cardiology Reports, 18, 111, 10.1007/s11886-016-0793-y Hastings, 2001, A vertebrate fatty acid desaturase with Delta 5 and Delta 6 activities, Proc Natl Acad Sci, 98, 14304, 10.1073/pnas.251516598 Li, 2016, Cloning, expression and functional characterization of the polyunsaturated fatty acid elongase (ELOVL5) gene from sea cucumber (Apostichopus japonicus), Gene, 593, 217, 10.1016/j.gene.2016.08.023 Moon, 2003, Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade, J Biol Chem, 278, 7335, 10.1074/jbc.M211684200 Cinti, 1992, The fatty acid chain elongation system of mammalian endoplasmic reticulum, Prog Lipid Res, 31, 1, 10.1016/0163-7827(92)90014-A Ahn, 2008, Enzymatic pathways that regulat endocannabinoid signaling in the nervous system, Chem Rev, 108, 1687, 10.1021/cr0782067 Weller, 2016, Leukocyte lipid bodies – structure and sunction ss “Eicosasomes”, Trans Am Clin Climatol Assoc, 127, 328 Tallima, 2015, Praziquantel and arachidonic acid combination — An Innovative Approach to the Treatment of Schistosomiasis, 145 Neufeld, 1983, Arachidonate release and phosphatidic acid turnover in stimulated human platelets, J Biol Chem, 258, 2461, 10.1016/S0021-9258(18)32948-X Zakim, 2000, Thermodynamics of fatty acid transfer, J Membr Biol, 176, 101, 10.1007/s002320001080 Spector, 1975, Structure and lipid binding properties of serum albumin, Methods Enzymol, 1986, 320 Mcarthur, 1999, Cellular uptake and intracellular trafficking of long chain fatty acids, J Lipid Res, 40, 1371, 10.1016/S0022-2275(20)33379-4 Dennis, 2011, Phospholipase A2 enzymes: Physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention, Chem Rev, 111, 6130, 10.1021/cr200085w Kano, 2009, Enndocannabinoid-mediated control of synaptic transmission, Physiol Rev, 89, 309, 10.1152/physrev.00019.2008 Bruntz, 2014, Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer, Pharmacol Rev, 66, 1033, 10.1124/pr.114.009217 Ishimoto, 1994, Contribution of phospholipases A2, D to arachidonic acid liberation and prostaglandin D2, formation with increase in intracellular Ca2+ concentration in rat peritoneal mast cells, Eur J Biochem, 219, 401, 10.1111/j.1432-1033.1994.tb19952.x Dennis, 2015, Eicosanoid storm in infection and inflammation, Nat Rev Immunol, 15, 511, 10.1038/nri3859 Jayadev, 1994, Identification of arachidonic-acid as a mediator of sphingomyelin hydrolysis in response to tumor-necrosis-factor-alpha, J Biol Chem, 269, 5757, 10.1016/S0021-9258(17)37526-9 Tallima, 2013, Solving the riddle of the lung-stage schistosomula paved the way to a novel remedy and an efficacious vaccine for schistosomiasis, 179 Harizi, 2005, The impact of eicosanoids on the crosstalk between innate and adaptive immunity: The key roles of dendritic cells, Tissue Antigens, 65, 507, 10.1111/j.1399-0039.2005.00394.x Denisenko, 2015, The role of arachidonic acid metabolites (Endocannabinoids and Eicosanoids) in the immune processes : A review, Int J Chem Biomed Sci, 1, 70 Drenjančević, 2016, The metabolites of arachidonic acid in microvascular function Morrow, 1990, A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism, Proc Natl Acad Sci U S A, 87, 9383, 10.1073/pnas.87.23.9383 Balazy, 2004, Biological nitration of arachidonic acid, Curr Vasc Pharmacol, 2, 81, 10.2174/1570161043476465 Norris, 2011, Specificity of eicosanoid production depends on the TLR-4-stimulated macrophage phenotype, J Leukoc Biol, 90, 563, 10.1189/jlb.0311153 Folco, 2006, Eicosanoid transcellular biosynthesis: From cell-cell interactions to in Vivo tissue responses, Pharmacol Rev, 58, 375, 10.1124/pr.58.3.8 Dahinden, 1985, Leukotriene C4 production by murine mast cells: evidence of a role for extracellular leukotriene A4, Proc Natl Acad Sci USA, 82, 6632, 10.1073/pnas.82.19.6632 Dickinson, 2004, Stabilization of leukotriene A 4 by epithelial fatty acid-binding Protein in the rat basophilic leukemia cell, J Biol Chem, 279, 7420, 10.1074/jbc.M311404200 Von Moltke, 2012, Rapid induction of inflammatory lipid mediators by the inflammasome in vivo, Nature, 490, 107, 10.1038/nature11351 Li, 2013, NCoR repression of LXRs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acids, Cell, 155, 200, 10.1016/j.cell.2013.08.054 Coulombe, 2014, Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages, Immunity, 40, 554, 10.1016/j.immuni.2014.02.013 Norris, 2014, Phospholipase A2 regulates eicosanoid class switching during inflammasome activation, Proc Natl Acad Sci USA, 111, 12746, 10.1073/pnas.1404372111 Mandal, 2008, The nuclear membrane organization of leukotriene synthesis, Proc Natl Acad Sci USA, 105, 20434, 10.1073/pnas.0808211106 Miki, 2013, Lymphoid tissue phospholipase A 2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators, J Exp Med, 210, 1217, 10.1084/jem.20121887 Tay, 1995, Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers, Genomics, 26, 138, 10.1016/0888-7543(95)80093-2 Kramer, 1991, The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells, J Biol Chem, 266, 5268, 10.1016/S0021-9258(19)67782-3 Clark, 1991, A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP, Cell, 65, 1043, 10.1016/0092-8674(91)90556-E Stahl, 1999, Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism, Cell, 97, 349, 10.1016/S0092-8674(00)80744-8 Sumida, 1993, Role of fatty acids in signal transduction: Modulators and messengers, Prostaglandins, Leukot Essent Fat Acids, 48, 117, 10.1016/0952-3278(93)90019-S Channon, 1990, A calcium-dependent mechanism for associating a soluble A2 with membrane in the macrophage cell a calcium-dependent mechanism for associating a soluble phospholipase A2 with membrane in the macrophage, J Biol Chem, 265, 5409, 10.1016/S0021-9258(19)39374-3 Gijón, 1999, Role of phosphorylation sites and the C2 domain in regulation of cytosolic phospholipase A2, J Cell Biol, 145, 1219, 10.1083/jcb.145.6.1219 Perisic, 1998, Crystal structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2, J Biol Chem, 273, 1596, 10.1074/jbc.273.3.1596 Xu, 1998, Solution structure and membrane interactions of the C2 domain of cytosolic phospholipase A2, J Mol Biol, 280, 485, 10.1006/jmbi.1998.1874 Hsu, 2008, Calcium binding rigidifies the C2 domain and the intradomain interaction of GIVA phospholipase A2 as revealed by hydrogen/deuterium exchange mass spectrometry, J Biol Chem, 283, 9820, 10.1074/jbc.M708143200 Lin, 1993, CPLA2 is phosphorylated and activated by MAP kinase, Cell, 72, 269, 10.1016/0092-8674(93)90666-E Nemenoff, 1993, Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C, J Biol Chem, 268, 1960, 10.1016/S0021-9258(18)53948-X Carvalho, 1996, Identification of phosphorylation sites of human 85-kDa cytosolic phospholipase A2 expressed in insect cells and present in human monocytes, J Biol Chem, 271, 6987, 10.1074/jbc.271.12.6987 Naraba, 1998, Segregated coupling of phospholipases A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages, J Immunol, 160, 2974, 10.4049/jimmunol.160.6.2974 Hata, 2004, Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation, Pharmacol Ther, 103, 147, 10.1016/j.pharmthera.2004.06.003 Brock, 1999, Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2, J Biol Chem, 274, 11660, 10.1074/jbc.274.17.11660 Chandrasekharan, 2002, COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression, Proc Natl Acad Sci USA, 99, 13926, 10.1073/pnas.162468699 Smith, 2012, Cyclooxygenase (COX) inhibitors and the newborn kidney, Pharmaceuticals, 5, 1160, 10.3390/ph5111160 Schneider, 2009, Control of oxygenation in lipoxygenase and cyclooxygenase catalysis, Chem Biol, 14, 473, 10.1016/j.chembiol.2007.04.007 Smith, 1991, The eicosanoids: cyclooxygenase, lipoxygenase, and epoxygenase pathways, 297 Hennekens, 1997, Aspirin as a therapeutic agent in cardiovascular disease, Circulation, 96, 2751, 10.1161/01.CIR.96.8.2751 Langenbach, 1999, Cyclooxygenase knockout mice models for elucidation isoform-specific functions, Biochem Pharmacol, 58, 1237, 10.1016/S0006-2952(99)00158-6 Lim, 1997, Multiple female reproductive failure in cyclooxygenase 2 deficient in mice, Cell, 91, 197, 10.1016/S0092-8674(00)80402-X Li, 1999, The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2 -/-, but not cyclooxygenase-1-/- mice, Brain Res, 825, 86, 10.1016/S0006-8993(99)01225-1 Howe, 2005, HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cylcooxygenase-2- knockout mice, Cancer Res, 65, 10113, 10.1158/0008-5472.CAN-05-1524 Teismann, 2003, Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration, PNAS, 100, 5473, 10.1073/pnas.0837397100 Hunot, 2004, JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of parkinson's disease, PNAS, 1–1, 665, 10.1073/pnas.0307453101 Rhai-Bhogal, 2017, Microarray analysis of gene expression in the cyclooxygenase knockout mice - a connection to autism spectrum disorder, Eur J Neurosci, 1 Ushikubi, 1989, Purification of the thromboxane A2/prostaglandin H2 receptor from human blood platelets, J Biol Chem, 264, 16496, 10.1016/S0021-9258(19)84733-6 Hirata, 1991, Cloning and expression of cDNA for a human thromboxane A2 receptor, Nature, 349, 617, 10.1038/349617a0 Narumiya, 1999, Prostanoid receptors: Structures, properties, and functions, Physiol Rev, 79, 1193, 10.1152/physrev.1999.79.4.1193 Hirai, 2001, Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor Crth2, J Exp Med, 193, 255, 10.1084/jem.193.2.255 Savarese, 1992, In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors, Biochem J, 283, 1, 10.1042/bj2830001 Coleman, 1994, International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes, Pharmacol Rev, 46, 205 Ishikawa, 1996, Mapping of the genes encoding mouse prostaglandin D, E, and F and prostacyclin receptors, Genomics, 32, 285, 10.1006/geno.1996.0118 Taketo, 1994, Mapping of the genes encoding mouse thromboxane A2 receptor and prostaglandin E receptor subtypes EP2 and EP3, Genomics, 19, 585, 10.1006/geno.1994.1113 Duncan, 1995, Chromosomal localization of the human prostanoid receptor gene family, Genomics, 25, 740, 10.1016/0888-7543(95)80022-E Nuseng, 1993, Characterization and chromosomal mapping of the human thromboxane A2 receptor Gene, J Biol Chem, 268, 25253, 10.1016/S0021-9258(19)74595-5 Ushikubi, 1995, Molecular biology of prostanoid receptors; an overview, J Lipid Mediat Cell Signal, 12, 343, 10.1016/0929-7855(95)00022-I Toh, 1995, Molecular evolution of receptors for eicosanoids, FEBS Lett, 361, 17, 10.1016/0014-5793(95)00129-W Pettipher, 2007, Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases, Nat Rev Drug Discov, 6, 313, 10.1038/nrd2266 Ricciotti, 2011, Prostaglandins and inflammation, Arterioscler Thromb Vasc Biol, 31, 986, 10.1161/ATVBAHA.110.207449 Cheng, 2006, Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans, Proc Natl Acad Sci USA, 103, 6682, 10.1073/pnas.0601574103 Liang, 2005, Prostaglandin D2 mediates neuronal protection via the DP1 receptor, J Neurochem, 92, 477, 10.1111/j.1471-4159.2004.02870.x Taketomi, 2013, Mast cell maturation is driven via a group III phospholipase A2 - prostaglandin D2 –DP1 receptor paracrine axis, Nat Immunol, 14, 554, 10.1038/ni.2586 Spik, 2005, Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in Mouse, J Immunol, 174, 3703, 10.4049/jimmunol.174.6.3703 Schratl, 2007, The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking, J Immunol, 179, 4792, 10.4049/jimmunol.179.7.4792 Schlondorff, 1986, Renal prostaglandin synthesis: Sites of production and specific actions of prostaglandins, Am J Med, 81, 1, 10.1016/0002-9343(86)90903-4 Shinomiya, 2001, Regulation of TNF-α and interleukin-10 production by prostaglandins I2 and E2: Studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists, Biochem Pharmacol, 61, 1153, 10.1016/S0006-2952(01)00586-X Levy, 2001, Lipid mediator class switching during acute inflammation: signals in resolution, Nat Publ Gr, 2, 612 Bray, 1981, Leukotriene B4: a Mediator of vascular permeability, Br J Pharmacol, 72, 483, 10.1111/j.1476-5381.1981.tb11000.x Lin, 2006, Prostaglandin E 2 receptor EP4 contributes to inflammatory pain hypersensitivity, J Pharmacol Exp Ther, 319, 1096, 10.1124/jpet.106.105569 Moriyama, 2005, Sensitization of TRPV1 by EP 1 and IP reveals peripheral nociceptive mechanism of prostaglandins, Mol Pain, 1, 3, 10.1186/1744-8069-1-3 Lazarus, 2007, EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses, Nat Neurosci, 10, 1131, 10.1038/nn1949 Jakobsson, 1999, Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target, Proc Natl Acad Sci U S A, 96, 7220, 10.1073/pnas.96.13.7220 Morimoto, 2014, Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation, J Immunol, 192, 1130, 10.4049/jimmunol.1300290 Minami, 2001, Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice, Br J Pharmacol, 133, 438, 10.1038/sj.bjp.0704092 Moore, 1982, Prostaglandins, prostacyclin and thromboxanes, Biochem Educ, 10, 82, 10.1016/0307-4412(82)90081-4 Murata, 1997, Altered pain perception and inflammatory response in mice lacking prostacyclin receptor, Nature, 388, 678, 10.1038/41780 Moncada, 1977, Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium, Thromb Res, 11, 323, 10.1016/0049-3848(77)90185-2 Weiss, 1979, Prostacyclin (Prostaglandin 12, PGI2) inhibits platelet adhesion and thrombus formation on subendothelium, Blood, 53, 244, 10.1182/blood.V53.2.244.244 Basu, 2007, Novel cyclooxygenase-catalyzed bioactive prostaglandin F2α from physiology to new principles in inflammation, Med Res Rev, 27, 435, 10.1002/med.20098 Hartwig, 1995, Thrombin receptor ligation and activated rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets, Cell, 82, 643, 10.1016/0092-8674(95)90036-5 Auch-schwelk, 1990, Thromboxane A2 receptor antagonists inhibit endothelium-dependent contractions, Hypertension, 15, 699, 10.1161/01.HYP.15.6.699 Cogolludo, 2003, Thromboxane A2-induced inhibition of voltage-gated K+ channels and pulmonary vasoconstriction: Role of protein kinase C, Circ Res, 93, 656, 10.1161/01.RES.0000095245.97945.FE Kabashima, 2003, Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity, Nat Immunol, 4, 694, 10.1038/ni943 Vogel, 2010, Applicability of the triad concept for the positional specificity of mammalian lipoxygenases, J Biol Chem, 285, 5369, 10.1074/jbc.M109.057802 Newcomer, 2015, The structural basis for specificity in lipoxygenase catalysis, Protein Sci, 24, 298, 10.1002/pro.2626 Chavis, 2000, Lipoxins and other arachidonate derived mediators in bronchial asthma, Thorax, 55, S38, 10.1136/thorax.55.suppl_2.S38 Izumi, 2002, Leukotriene receptors : classification, gene expression and signal transduction, J Biochem, 132, 1, 10.1093/oxfordjournals.jbchem.a003185 Serhan, 1990, Lipoxin formation during human neutrophil-platelet interactions: Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro, J Clin Invest, 85, 772, 10.1172/JCI114503 Serhan, 1984, Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes, Proc Natl Acad Sci USA, 81, 5335, 10.1073/pnas.81.17.5335 Serhan, 2005, Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution, Prostaglandins Leukot Essent Fatty Acids, 73, 141, 10.1016/j.plefa.2005.05.002 Murphy, 1992, A structural homologue of the N-formyl peptide receptor: Characterization and chromosome mapping of a peptide chemoattractant receptor family, J Biol Chem, 267, 7637, 10.1016/S0021-9258(18)42563-X Bao, 1992, Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19, Genomics, 13, 437, 10.1016/0888-7543(92)90265-T Bray, 1986, Leukotrienes in inflammation, Agents Actions, 19, 87, 10.1007/BF01977263 Samuelsson, 1983, Leukotrienes : Mediators of immediate hypersensitivity reactions and inflammation, Science, 220, 568, 10.1126/science.6301011 Lämmermann, 2013, Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo, Nature, 498, 371, 10.1038/nature12175 Narala, 2010, Leukotriene B4 is a physiologically relevant endogenous peroxisome proliferator-activated receptor-α agonist, J Biol Chem, 285, 22067, 10.1074/jbc.M109.085118 Murakami, 1999, Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha, Biochem Biophys Res Commun, 260, 609, 10.1006/bbrc.1999.0951 Ahorny, 1998, Pharmacology of leukotriene receptor antagonists, Am J Respir Crit Care Med, 157, S214, 10.1164/ajrccm.157.6.mar-2 Moos, 2008, Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport, FASEB J, 22, 4352, 10.1096/fj.08-113274 Serhan, 2014, Novel pro-resolving lipid mediators in inflammation are leads for resolution physiology, Nature, 510, 92, 10.1038/nature13479 Collin, 2004, Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice by the 5-lipoxygenase inhibitor Zileuton, J Leukoc Biol, 76, 961, 10.1189/jlb.0604338 Cyrus, 1999, Disruption of the 12/15- lipoxygenase gene diminshes atherosclerosis in apo E - deficient mice, J Clin Invest, 103, 1597, 10.1172/JCI5897 Bleich, 1999, Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice, J Clin Invest, 103, 1431, 10.1172/JCI5241 Imai, 2016, Lipids and immunoinflammatory pathways of beta cell destruction, Diabetologia, 59, 673, 10.1007/s00125-016-3890-y Luo, 2011, Eicosanoids, beta-cell function, and diabetes, Prostaglandins Other Lipid Mediat, 95, 1, 10.1016/j.prostaglandins.2011.06.001 Neckár̆a J, Kopkanb L, Huskováb Z, Kolár̆a F, Papous̆eka F, Kramerd HJ, et al. Inhibition of soluble epoxide hydrolase by cis-4-[4-(3- adamantan-1-yl-ureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension. Clin Sci (Lond) 2012;122(11):513–25. Fan, 2015, Cytochrome P450 eicosanoids in hypertension and renal disease, Curr Opin Nephrol Hypertens, 24, 37, 10.1097/MNH.0000000000000088 Simon, 2008, Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain, J Biol Chem, 283, 9341, 10.1074/jbc.M707807200 Arreaza, 1997, The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine, Neurosci Lett, 234, 59, 10.1016/S0304-3940(97)00673-3 Izzo, 2011, Unique pathway for anandamide synthesis and liver regeneration, Proc Natl Acad Sci USA, 108, 6339, 10.1073/pnas.1103566108 Mukhopadhyay, 2011, Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver, Proc Natl Acad Sci USA, 108, 6323, 10.1073/pnas.1017689108 Cadas, 1997, Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain, J Neurosci, 17, 1226, 10.1523/JNEUROSCI.17-04-01226.1997 Ritter, 2012, Production and actions of the anandamide metabolite prostamide E2 in the Renal Medulla, J Pharmacol Exp Ther, 342, 770, 10.1124/jpet.112.196451 Berridge, 2013, Neuroscience of affect: Brain mechanisms of pleasure and displeasure, Curr Opin Neurobiol, 23, 294, 10.1016/j.conb.2013.01.017 Goonawardena, 2015, Modulation of food consumption and sleep–wake cycle in mice by the neutral CB1 antagonist ABD459, Behav Pharmacol, 26, 289, 10.1097/FBP.0000000000000108 Fam, 2003, The isoprostanes: unique products of arachidonic acid oxidation-a review, Curr Med Chem, 10, 1723, 10.2174/0929867033457115 Trostchansky, 2007, Synthesis, isomer characterization, and anti-Inflammatory properties of nitroarachidonate, Biochemistry, 46, 45, 10.1021/bi602652j